mjr
Comfy armchair to one person & a plank to the next
- Location
- mostly Norfolk, sometimes Somerset
And yet, reportedly, the EU is paying about €2/dose, the UK €3/dose and SA €5.50/dose. How all of those work out as cost price will be an interesting exercise in accounting in a year or two.AZ have stated, and indeed are contractually obliged by their license with Oxford (Oxford refused to collaborate with firms who wouldn't do this) to provide at cost price
And yet, AZ offered to fulfil its EU contract from both EU and UK factories, so should one EU factory not performing optimally really produce a 66% reduction in Q1 supply and a >50% reduction in Q2? No wonder Italy thought it smelt a rat and blocked an export from EU factories to Australia.Signing up to the contracts enabled investment in supply chains; specifically a UK based supply chain first, then an EU based supply chain when (later) the EU signed up.
But we discussed this many pages ago. I doubt I will convince you that this is an AZ screwup as much as an EC one: it seems the EC signed a contract without enough remedies for the situation they are now suffering, but it also seems like AZ effectively included in the sale UK production that was really zero because it was all already sold to the UK, seeing a way to handle any shortfall by sending letters.